- Home
- ETON vs OSPN Comparison
ETON vs OSPN Comparison
Compare ETON & OSPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- OSPN
- Stock Information
- Founded
- ETON 2017
- OSPN 1991
- Country
- ETON United States
- OSPN United States
- Employees
- ETON N/A
- OSPN N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- OSPN EDP Services
- Sector
- ETON Health Care
- OSPN Technology
- Exchange
- ETON Nasdaq
- OSPN Nasdaq
- Market Cap
- ETON 498.8M
- OSPN 576.4M
- IPO Year
- ETON 2018
- OSPN 1998
- Fundamental
- Price
- ETON $18.35
- OSPN $11.85
- Analyst Decision
- ETON Strong Buy
- OSPN Strong Buy
- Analyst Count
- ETON 3
- OSPN 3
- Target Price
- ETON $29.67
- OSPN $19.67
- AVG Volume (30 Days)
- ETON 249.9K
- OSPN 267.4K
- Earning Date
- ETON 11-06-2025
- OSPN 10-30-2025
- Dividend Yield
- ETON N/A
- OSPN 3.10%
- EPS Growth
- ETON N/A
- OSPN 100.07
- EPS
- ETON N/A
- OSPN 1.49
- Revenue
- ETON $58,181,000.00
- OSPN $241,436,000.00
- Revenue This Year
- ETON $105.25
- OSPN $3.97
- Revenue Next Year
- ETON $40.84
- OSPN $5.44
- P/E Ratio
- ETON N/A
- OSPN $10.41
- Revenue Growth
- ETON 85.40
- OSPN N/A
- 52 Week Low
- ETON $8.24
- OSPN $12.51
- 52 Week High
- ETON $23.00
- OSPN $20.37
- Technical
- Relative Strength Index (RSI)
- ETON 45.34
- OSPN 23.89
- Support Level
- ETON $18.00
- OSPN $15.04
- Resistance Level
- ETON $18.92
- OSPN $16.18
- Average True Range (ATR)
- ETON 0.83
- OSPN 0.46
- MACD
- ETON -0.12
- OSPN -0.26
- Stochastic Oscillator
- ETON 45.30
- OSPN 16.39
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About OSPN OneSpan Inc.
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.